moxifloxacin has been researched along with Infections, Ureaplasma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crabb, DM; Duffy, LB; Waites, KB | 1 |
| Macía, M; Navarro, D; Romay, AB; Trastoy, R; Treviño, M; Veiga, E | 1 |
| Huang, J; Kong, Y; Qiao, Y; Ruan, Z; Song, J; Song, T; Xie, X; Zhang, J | 1 |
| Beeton, ML; Chalker, VJ; Jones, LC; Maxwell, NC; Spiller, OB | 1 |
| Bébéar, C; Bébéar, CM; Clerc, M; de Barbeyrac, B; Pereyre, S; Renaudin, H | 1 |
| Dan, M; Rosenberg, S; Samra, Z | 1 |
6 other study(ies) available for moxifloxacin and Infections, Ureaplasma
| Article | Year |
|---|---|
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections | 2008 |
Prevalence of genital Mycoplasma and response to eradication treatment in patients undergoing assisted reproductive techniques.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clindamycin; Doxycycline; Embryo Implantation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Prevalence; Real-Time Polymerase Chain Reaction; Reproductive Techniques, Assisted; Semen Analysis; Sex Factors; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Young Adult | 2019 |
Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ureaplasma; Ureaplasma Infections | 2015 |
Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; England; Epidemiological Monitoring; Fluoroquinolones; Gentamicins; Humans; Infant; Infant, Newborn; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Tetracycline; Ureaplasma; Ureaplasma Infections; Wales | 2016 |
Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
Topics: Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydia trachomatis; Female; Female Urogenital Diseases; Fluoroquinolones; Humans; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Quinolines; Ureaplasma; Ureaplasma Infections | 2008 |
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum | 2011 |